Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
10.01
-0.08 (-0.79%)
Sep 26, 2025, 3:04 PM CST
SHE:300009 Revenue
Anhui Anke Biotechnology (Group) had revenue of 663.43M CNY in the quarter ending June 30, 2025, with 3.22% growth. This brings the company's revenue in the last twelve months to 2.53B, down -12.09% year-over-year. In the year 2024, Anhui Anke Biotechnology (Group) had annual revenue of 2.54B, down -11.51%.
Revenue (ttm)
2.53B
Revenue Growth
-12.09%
P/S Ratio
6.60
Revenue / Employee
955.58K
Employees
2,647
Market Cap
16.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.54B | -329.71M | -11.51% |
Dec 31, 2023 | 2.87B | 534.69M | 22.94% |
Jan 1, 2023 | 2.33B | 162.30M | 7.48% |
Dec 31, 2021 | 2.17B | 467.35M | 27.47% |
Dec 31, 2020 | 1.70B | -11.11M | -0.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Shanghai United Imaging Healthcare | 10.98B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |